☆ 4.7 Editorial Material

Drug delivery advances in mitigating inflammation via matrix metalloproteinases in respiratory diseases

NANOMEDICINE (2021)

Journal

NANOMEDICINE

Volume 16, Issue 6, Pages 437-439

Publisher

FUTURE MEDICINE LTD

DOI: 10.2217/nnm-2021-0016

Keywords

inflammation; matrix metalloproteinase; nanoparticles; novel drug delivery; respiratory diseases

Categories

Biotechnology & Applied Microbiology Nanoscience & Nanotechnology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Editorial Material Biotechnology & Applied Microbiology

Applications of extracellular vesicles as a drug-delivery system for chronic respiratory diseases

Bikash Manandhar, Keshav Raj Paudel, Nisha Panth, Philip Hansbro, Brian G. Oliver, Kamal Dua

Summary: Advancements in nanotechnology have led to the development of smart nanoparticles that can transport drugs to specific sites effectively. Liposomes, as nanocarriers, can stably incorporate various types of drug molecules and release them inside cells by fusing with the cell membrane. However, liposomal drug carriers still have safety and stability issues.

NANOMEDICINE (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Lipid Nanoparticles as Delivery Vehicles for Inhaled Therapeutics

Ellenmae W. X. Leong, Ruowen Ge

Summary: Lipid nanoparticles (LNPs) have emerged as a powerful non-viral carrier for drug delivery. Current investigations are focusing on applying LNPs to deliver inhaled therapeutics directly to the lungs, particularly in respiratory diseases. This review evaluates the advantages and challenges of pulmonary drug delivery system and provides a perspective on the future prospects of LNP-mediated delivery of inhaled therapeutics for respiratory diseases.

BIOMEDICINES (2022)

Add to Collection

Article Chemistry, Physical

Recent applications and strategies in nanotechnology for lung diseases

Wenhao Zhong, Xinyu Zhang, Yunxin Zeng, Dongjun Lin, Jun Wu

Summary: Lung diseases, including COVID-19 and lung cancers, pose a significant threat to human health, with treatment and diagnosis becoming increasingly challenging. Nanotechnology, as an emerging technology, has shown promise in improving targeted drug delivery in the lungs, offering potential for enhancing therapeutic effects.

NANO RESEARCH (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Role of chitosan based nanomedicines in the treatment of chronic respiratory diseases

Nisha Gulati, Kamal Dua, Harish Dureja

Summary: Chitosan-loaded nanomedicines provide a promising approach for the treatment of respiratory diseases, showcasing a wide range of pharmacological actions that make them particularly effective in chronic respiratory conditions.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Nanotechnology based advanced therapeutic strategies for targeting interleukins in chronic respiratory diseases

Md Sadique Hussain, Parvarish Sharma, Daljeet Singh Dhanjal, Navneet Khurana, Manish Vyas, Neha Sharma, Meenu Mehta, Murtaza M. Tambuwala, Saurabh Satija, Sukhwinder Singh Sohal, Brian G. G. Oliver, Hari S. Sharma

Summary: Chronic respiratory diseases affect millions of people globally, causing harm to patients' health and impacting families and societies negatively. Current treatments focus on alleviating symptoms rather than delivering therapeutic agents effectively.

CHEMICO-BIOLOGICAL INTERACTIONS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Targeting eosinophils in chronic respiratory diseases using nanotechnology-based drug delivery

Parvarish Sharma, Daljeet Singh Dhanjal, Chirag Chopra, Murtaza M. Tambuwala, Sukhwinder Singh Sohal, Peter J. Van der Spek, Hari S. Sharma, Saurabh Satija

Summary: This review provides knowledge about the role of eosinophils in chronic respiratory diseases and discusses the potential of nanocarrier drug delivery systems for targeted treatment.

CHEMICO-BIOLOGICAL INTERACTIONS (2022)

Add to Collection

Article Pharmacology & Pharmacy

Nanostructures for drug delivery in respiratory diseases therapeutics: Revision of current trends and its comparative analysis

Luis Angel Ibarra-Sanchez, Ana Gamez-Mendez, Manuel Martinez-Ruiz, Erik Francisco Najera-Martinez, Brando Alan Morales-Flores, Elda M. Melchor-Martinez, Juan Eduardo Sosa-Hernandez, Roberto Parra-Saldivar, Hafiz M. N. Iqbal

Summary: Respiratory diseases are a major cause of death and disability globally, and nanotechnology shows promise in improving drug delivery and treatment outcomes. While progress has been made in cancer therapies, recent research has focused on the application of nanotechnology in other pulmonary diseases. The integration of different nanostructures may improve drug bioavailability, transport, and delivery compared to traditional respiratory therapy.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2022)

Add to Collection

Review Nutrition & Dietetics

Unravelling the Therapeutic Potential of Nano-Delivered Functional Foods in Chronic Respiratory Diseases

Dvya Delilaa Clarence, Keshav Raj Paudel, Bikash Manandhar, Sachin Kumar Singh, Hari Prasad Devkota, Jithendra Panneerselvam, Vivek Gupta, Nitin Chitranshi, Nitin Verma, Sonia Saad, Gaurav Gupta, Philip Michael Hansbro, Brian Gregory Oliver, Thiagarajan Madheswaran, Kamal Dua, Dinesh Kumar Chellappan

Summary: Chronic inflammation of the respiratory tract is a major public health issue that can lead to various chronic respiratory diseases. The conventional drug therapies only address the symptoms, while the combination of nutraceuticals and nanoparticles has gained attention as it can not only improve symptoms, but also has anti-inflammatory and antioxidant properties with fewer adverse effects.

NUTRIENTS (2022)

Add to Collection

Article Chemistry, Applied

Biomedical applications of polysaccharide nanoparticles for chronic inflammatory disorders: Focus on rheumatoid arthritis, diabetes and organ fibrosis

Prince Allawadhi, Vishakha Singh, Kannan Govindaraj, Isha Khurana, Lopmudra P. Sarode, Umashanker Navik, Anil Kumar Banothu, Ralf Weiskirchen, Kala Kumar Bharani, Amit Khurana

Summary: Polysaccharides are important biological polymers with diverse applications. Polysaccharide nanoparticles exhibit excellent drug delivery properties and therapeutic effects, making them promising for applications in diabetes, organ fibrosis, and arthritis.

CARBOHYDRATE POLYMERS (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Role of Matrix Metalloproteinases in Musculoskeletal Diseases

Lokender Kumar, Monish Bisen, Azhar Khan, Pradeep Kumar, Sanjay Kumar Singh Patel

Summary: This review discusses the role of MMPs in skeletal muscle function, muscle injury and repair, as well as the potential applications of MMPs in the treatment of musculoskeletal disorders.

BIOMEDICINES (2022)

Add to Collection

Article Medicine, General & Internal

A Comparative Analysis of Treatment-Related Changes in the Diagnostic Biomarker Active Metalloproteinase-8 Levels in Patients with Periodontitis

Mutlu Keskin, Juulia Rintamarttunen, Emre Gulcicek, Ismo T. Raisanen, Shipra Gupta, Taina Tervahartiala, Tommi Patila, Timo Sorsa

Summary: This study investigated treatment-related changes in aMMP-8 levels and its correlation with clinical parameters in individuals with periodontitis. The results showed that the chairside PoC aMMP-8 test has promise for the real-time diagnosis and monitoring of periodontal therapy.

DIAGNOSTICS (2023)

Add to Collection

Review Pharmacology & Pharmacy

Nanoparticle-based drug delivery systems for the treatment of cardiovascular diseases

Fangyu Yang, Jianjiang Xue, Guixue Wang, Qizhi Diao

Summary: Cardiovascular disease is a common health problem worldwide, and current pharmaceutical treatment is suboptimal. Nanoparticle-based drug delivery systems have shown significant therapeutic effects and offer a safer and more effective strategy for the treatment of cardiovascular diseases.

FRONTIERS IN PHARMACOLOGY (2022)

Add to Collection

Review Gastroenterology & Hepatology

Novel drug delivery systems for inflammatory bowel disease

Farah Yasmin, Hala Najeeb, Shehryar Shaikh, Muhammad Hasanain, Unaiza Naeem, Abdul Moeed, Thoyaja Koritala, Syedadeel Hasan, Salim Surani

Summary: Inflammatory bowel disease (IBD) is a chronic illness with complex pathogenesis. The current treatment methods have limitations, so novel drug delivery systems are introduced to overcome these limitations.

WORLD JOURNAL OF GASTROENTEROLOGY (2022)

Add to Collection

Review Materials Science, Biomaterials

Current advances in drug delivery of nanoparticles for respiratory disease treatment

Beatriz Rossi Canuto de Menezes, Karla Faquine Rodrigues, Vanessa Modelski Schatkoski, Raissa Monteiro Pereira, Renata Guimaraes Ribas, Thais Larissa do Amaral Montanheiro, Gilmar Patrocinio Thim

Summary: Respiratory diseases are on the rise globally, leading to increased hospital admissions and deaths. Nanoparticles (NPs) have shown promise as drug delivery systems, improving the efficacy of treatments for CRDs and ARIs. Despite opportunities in the field of NPs, challenges also exist.

JOURNAL OF MATERIALS CHEMISTRY B (2021)

Add to Collection

Article Polymer Science

Novel Thymoquinone Nanoparticles Using Poly(ester amide) Based on L-Arginine-Targeting Pulmonary Drug Delivery

Eman Zmaily Dahmash, Dalia Khalil Ali, Hamad S. Alyami, Hussien AbdulKarim, Mohammad H. Alyami, Alhassan H. Aodah

Summary: Thymoquinone (TQ), the main active constituent of Nigella sativa, has shown broad-spectrum antimicrobial, antioxidant, and anti-inflammatory effects. However, its clinical use has been hindered by limited solubility and bioavailability. To overcome these limitations, a targeted delivery system using nanotechnology to deliver TQ to the lungs is needed.

POLYMERS (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Chitosan modified 5-fluorouracil nanostructured lipid carriers for treatment of diabetic retinopathy in rats: A new dimension to an anticancer drug

Deep Shikha Sharma, Sheetu Wadhwa, Monica Gulati, Bimlesh Kumar, Nitin Chitranshi, Vivek Kumar Gupta, Mohammed Alrouji, Sharif Alhajlah, Othman AlOmeir, Sukriti Vishwas, Rubiya Khursheed, Sumant Saini, Ankit Kumar, Shaik Rahana Parveen, Gaurav Gupta, Flavia Zacconi, Dinesh Kumar Chellappan, Andrew Morris, Raimar Loebenberg, Kamal Dua, Sachin Kumar Singh

Summary: Diabetic retinopathy is a chronic complication of diabetes characterized by damage to retinal blood vessels and potential loss of vision. Current treatment strategies are expensive, invasive, and require specialized administration. This study explores the development of a non-invasive topical formulation that can penetrate deep into the retina, treat damaged vessels, and provide sustained release. Novel drug delivery systems have shown success in treating diabetic retinopathy, and in this study, chitosan modified 5-Fluorouracil Nanostructured Lipid Carriers (CS-5-FU-NLCs) were prepared and optimized.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2023)

Add to Collection

Review Rheumatology

Vitamin D-A prominent immunomodulator to prevent COVID-19 infection

Sumel Ashique, Kirti Gupta, Gaurav Gupta, Neeraj Mishra, Sachin Kumar Singh, Sheetu Wadhwa, Monica Gulati, Harish Dureja, Flavia Zacconi, Brian G. Oliver, Keshav Raj Paudel, Philip M. Hansbro, Dinesh Kumar Chellappan, Kamal Dua

Summary: This study summarizes the research on the use of vitamin D for COVID-19 treatment and prevention. Vitamin D supplementation is considered an effective option to enhance immune response and prevent the spread of infection. Vitamin D acts as an immunomodulator, treating infected lung tissue by improving immune response and suppressing inflammatory reactions.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2023)

Add to Collection

Article Biology

Tenascin C in Lung Diseases

Chantal Donovan, Xu Bai, Yik Lung Chan, Min Feng, Kin-Fai Ho, Hai Guo, Hui Chen, Brian G. Oliver

Summary: TNC expression is increased during lung development, in offspring following maternal PM exposure, asthma, COPD, and lung cancer tissues. Therefore, targeting TNC may provide a novel therapeutic target for lung diseases.

BIOLOGY-BASEL (2023)

Add to Collection

Article Engineering, Multidisciplinary

Development of 3D-Bioprinted Colitis-Mimicking Model to Assess Epithelial Barrier Function Using Albumin Nano-Encapsulated Anti-Inflammatory Drugs

Abdulmajeed G. Almutary, Abdullah M. Alnuqaydan, Saleh A. Almatroodi, Hamid A. Bakshi, Dinesh Kumar Chellappan, Murtaza M. Tambuwala

Summary: Physiological barrier function is difficult to replicate in vitro, but a colitis-like condition model generated through 3D bioprinting can evaluate the barrier function of nanoencapsulated anti-inflammatory drugs. Histological characterization confirmed the presence of the disease in the 3D-bioprinted constructs, and a comparison of proliferation rates in 2D monolayer and 3D-bioprinted models was conducted. This model can be implemented as an effective tool for predicting drug efficacy and toxicity in the drug development process.

BIOMIMETICS (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Extracellular Vesicles Released from Cancer Cells Promote Tumorigenesis by Inducing Epithelial to Mesenchymal Transition via β-Catenin Signaling

Vamshikrishna Malyla, Keshav Raj Paudel, Gabriele De Rubis, Nicole G. Hansbro, Philip M. Hansbro, Kamal Dua

Summary: Lung cancer is a major global cause of cancer-related deaths due to a lack of early diagnostics and effective treatments. In a study, EVs derived from A549 lung adenocarcinoma cells were transferred to healthy human bronchial epithelial cells. It was found that the EVs carry oncogenic proteins involved in promoting tumor growth and invasion through the EMT pathway regulated by beta-catenin. This study suggests that cancer-cell-derived EVs can induce tumorigenesis in neighboring healthy cells.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Review Pharmacology & Pharmacy

Tackling the cytokine storm using advanced drug delivery in allergic airway disease

Vyoma K. Patel, Sukriti Vishwas, Rajan Kumar, Gabriele De Rubis, Shakti D. Shukla, Keshav Raj Paudel, Bikash Manandhar, Thakur Gurjeet Singh, Dinesh Kumar Chellappan, Monica Gulati, Indu Pal Kaur, Venkata Sita Rama Raju Allam, Philip M. Hansbro, Brian G. Oliver, Ronan MacLoughlin, Sachin Kumar Singh, Kamal Dua

Summary: Asthma is a chronic inflammatory airway disease that presents a huge burden worldwide. Overproduction of pro-inflammatory cytokines triggers an uncontrolled inflammatory response known as 'cytokine storm', leading to disease progression and fatal consequences. Targeting cytokine overproduction and signaling may provide a promising approach for asthma treatment. This review discusses pharmacological strategies, drug delivery systems, and clinical trial findings that may overcome the limitations of current therapies.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2023)

Add to Collection

Article Pharmacology & Pharmacy

Anticancer activity of NF?B decoy oligonucleotide-loaded nanoparticles against human lung cancer

Vinod Kumar Kannaujiya, Gabriele De Rubis, Keshav Raj Paudel, Bikash Manandhar, Dinesh Kumar Chellappan, Sachin Kumar Singh, Ronan MacLoughlin, Gaurav Gupta, Dikaia Xenaki, Pradeep Kumar, Philip Michael Hansbro, Brian Gregory George Oliver, Peter Richard Wich, Kamal Dua

Summary: Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related deaths worldwide, and current treatment options are limited. Inhibition of NF kappa B, a master regulator of NSCLC, shows promise as an innovative therapeutic strategy. This study demonstrates the encapsulation of a hydrophilic NF kappa B decoy ODN into a dextran-based nanoparticle system, which effectively inhibits NF kappa B activity and exhibits promising anticancer activity against NSCLC.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2023)

Add to Collection

Review Medicine, General & Internal

The Complex Association between COPD and COVID-19

Nikhil T. Awatade, Peter A. B. Wark, Andrew S. L. Chan, S. M. Abdullah Al Mamun, Nurul Yaqeen Mohd Esa, Kazuto Matsunaga, Chin Kook M. Rhee, Philip M. Hansbro, Sukhwinder Singh Sohal

Summary: Chronic obstructive pulmonary disease (COPD) is a major contributor to illness and death worldwide. While COPD patients appear to be at higher risk for severe COVID-19 outcomes, it is still uncertain if they are more susceptible to acquiring SARS-CoV-2 infection. This comprehensive review examines the relationship between COPD and COVID-19, exploring the evidence on susceptibility to infection and disease severity. The review also considers factors such as smoking, corticosteroid use, socioeconomic factors, and genetics that may influence this association. The importance of managing COPD patients during the pandemic to minimize the risk of severe COVID-19 outcomes is highlighted.

JOURNAL OF CLINICAL MEDICINE (2023)

Add to Collection

Article Multidisciplinary Sciences

Design and synthesis of novel bis-pyridinium based-ionic liquids as potent antiparasitic agents

Esraa Abdelhamid Moneer, Basant A. Bakr, Sara H. Akl, Yahya H. Shahin, Bassma H. Elwakil, Mohamed Hagar, Keshav Raj Paudel, Ateyatallah Aljuhani, Mohamed Reda Aouad, Nadjet Rezki

Summary: Focused bis-pyridinium based-ionic liquids were synthesized and characterized using NMR-spectroscopic techniques. Compound 5 exhibited higher antiparasitic activity against Toxoplasma gondii compared to other compounds, showing potential as a replacement for the known drug pyrimethamine. Histopathological study also demonstrated the effectiveness of compound 5 on various tissues with better histological features compared to pyrimethamine treated group, suggesting a promising antiparasitic profile and fewer side effects.

HELIYON (2023)

Add to Collection

Article Immunology

Expression of targets of the RNA-binding protein AUF-1 in human airway epithelium indicates its role in cellular senescence and inflammation

Ilaria Salvato, Luca Ricciardi, Jessica Dal Col, Annunziata Nigro, Giorgio Giurato, Domenico Memoli, Assunta Sellitto, Erwin Pavel Lamparelli, Maria Assunta Crescenzi, Monica Vitale, Alessandro Vatrella, Francesco Nucera, Paola Brun, Federico Caicci, Paola Dama, Thomas Stiff, Leandro Castellano, Sobia Idrees, Matt D. Johansen, Alen Faiz, Peter A. Wark, Philip M. Hansbro, Ian M. Adcock, Gaetano Caramori, Cristiana Stellato

Summary: AU-rich-element factor-1 (AUF-1), an RNA-binding protein, is involved in posttranscriptional regulation of genes related to inflammation and cellular senescence, both of which are pathogenic mechanisms in chronic obstructive pulmonary disease (COPD). Decreased expression of AUF-1 is observed in bronchiolar epithelium of COPD patients and in human airway epithelial cells exposed to cytokines and cigarette smoke. This study identifies AUF-1-targeted transcripts and demonstrates its association with inflammation and senescence-related pathways in COPD.

FRONTIERS IN IMMUNOLOGY (2023)

Add to Collection

Letter Biology

CYTOTOXIC MECHANISMS OF BERBERINE-PHYTANTRIOL LIQUID CRYSTALLINE NANOPARTICLES AGAINST NON-SMALL-CELL LUNG CANCER

Keshav Raj Paudel, Bikash Manandhar, Sachin Kumar Singh, Gaurav Gupta, Philip Michael Hansbro, Dinesh Kumar Chellappan, Kamal Dua

EXCLI JOURNAL (2023)

Add to Collection

Letter Biology

THE VERSATILITY OF 18B-GLYCYRRHETINIC ACID IN ATTENUATING PULMONARY INFLAMMATORY DISORDERS

Mohamad Siddiq Bin Mohamad, Ruby-Jean Reyes, Gabriele De Rubis, Keshav Raj Paudel, Philip Michael Hansbro, Kamal Dua, Dinesh Kumar Chellappan

EXCLI JOURNAL (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.